[Federal Register Volume 70, Number 12 (Wednesday, January 19, 2005)]
[Notices]
[Page 3046]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-956]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Veterinary Medicine Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Veterinary Medicine Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on January 31, 2005, from 8
a.m. to 5:30 p.m.
Location: DoubleTree Hotel, Plaza II and III, 1750 Rockville Pike,
Rockville MD.
Contact Person: Aleta Sindelar, Center for Veterinary Medicine
(HFV-3), Food and Drug Administration, 7519 Standish Pl., Rockville MD
20855, 301-827-4515, or e-mail: [email protected]. Please call the
FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572
in the Washington, DC area), code 3014512548, for up-to-date
information on this meeting.
Agenda: The committee will discuss and make recommendations
regarding the voluntary recall of the drug product, PROHEART 6 (NADA
141-189), manufactured by Fort Dodge Animal Health. The committee will
also discuss the Center for Veterinary Medicine's risk management
strategy. The background material for this meeting will be posted on
the Internet when available and no later than 1 business day before the
meeting at http://www.fda.gov/ohrms/dockets/ac/04acdocs.htm (Scroll
down to the appropriate committee link).
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by January 21,
2005. Oral presentations from the public will be scheduled between
approximately 1 p.m. and 2 p.m. on January 31, 2005. Time allotted for
each presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person by January 21, 2005, and
submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Aleta Sindelar at
least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: January 11, 2005.
William K. Hubbard,
Associate Commissioner for Policy and Planning.
[FR Doc. 05-956 Filed 1-18-05; 8:45 am]
BILLING CODE 4160-01-S